Funding
In 2018, I sold my telehealth company, Advance Medical, to Teladoc. It was the culmination of over 15 years building a global healthtech company, and the beginning of the next stage of my career. Today, as a General Partner at Nina Capital, a specialist VC focused on healthtech, I work on the other side of the table. With constant discussion about what it means to be a VC that adds value – I often find myself wondering how best to draw on my founder experience as an advisor to the companies we invest in.
Vanta has announced its $150 million Series D funding round at a $4.15 billion valuation. The round was led by new investor Wellington Management, and included existing investors, Growth Equity at Goldman Sachs Alternatives, Sequoia, J.P. Morgan, Craft Ventures, Y Combinator, Atlassian Ventures and CrowdStrike Ventures. The funding brings Vanta’s total funds raised to $504 million since 2021.
ÄIO, an Estonian biotechnology company developing sustainable, non-animal fats and non-vegetable oils through innovative fermentation processes, has secured €1 million in funding to accelerate development of safer and more ecological alternatives to traditional oils used in cosmetics and chemical industry applications.
















